Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Husberg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Technology Assessment in Health Care|January 13, 2001
Socioeconomic costs of rheumatic diseases. Implications for technology assessmentD Jonsson, M Husberg
Lakartidningen|July 21, 2001
[Interest for more health information. Information given by health authorities and family is considered more reliable than information found on the Internet, based on a study in the county of Ostergotland]P Garpenby, M Husberg
Rheumatology (Oxford, England)|November 17, 2005
Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project)E Hallert, M Husberg, T Skogh
Scandinavian Journal of Rheumatology|July 21, 2020
Presence of anti-citrullinated protein antibodies and costs and disease activity in early rheumatoid arthritis - a 3-year follow-upM Husberg, L Bernfort, E Hallert
Scandinavian Journal of Rheumatology|April 4, 2018
Costs and disease activity in early rheumatoid arthritis in 1996-2000 and 2006-2011, improved outcome and shift in distribution of costs: a two-year follow-upM Husberg, L Bernfort, E Hallert
Annals of the Rheumatic Diseases|June 18, 2003
Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rateT Skogh, D Gustafsson, M Kjellberg, et al.
Scandinavian Journal of Rheumatology|February 9, 2016
Rheumatoid arthritis is still expensive in the new decade: a comparison between two early RA cohorts, diagnosed 1996-98 and 2006-09E Hallert, M Husberg, A Kalkan, et al.
Rheumatology (Oxford, England)|July 29, 2004
Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project)E Hallert, M Husberg, D Jonsson, et al.
Scandinavian Journal of Rheumatology|December 21, 2013
Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA projectE Hallert, M Husberg, A Kalkan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Differences Between Hypothetical and Experience-Based Value Sets for Eq-5d: Implications for Decision MakersM Aronsson, M Husberg, A Kalkan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Technology Assessment in Health Care|January 13, 2001
Socioeconomic costs of rheumatic diseases. Implications for technology assessmentD Jonsson, M Husberg
Lakartidningen|July 21, 2001
[Interest for more health information. Information given by health authorities and family is considered more reliable than information found on the Internet, based on a study in the county of Ostergotland]P Garpenby, M Husberg
Rheumatology (Oxford, England)|November 17, 2005
Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project)E Hallert, M Husberg, T Skogh
Scandinavian Journal of Rheumatology|July 21, 2020
Presence of anti-citrullinated protein antibodies and costs and disease activity in early rheumatoid arthritis - a 3-year follow-upM Husberg, L Bernfort, E Hallert
Scandinavian Journal of Rheumatology|April 4, 2018
Costs and disease activity in early rheumatoid arthritis in 1996-2000 and 2006-2011, improved outcome and shift in distribution of costs: a two-year follow-upM Husberg, L Bernfort, E Hallert
Annals of the Rheumatic Diseases|June 18, 2003
Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rateT Skogh, D Gustafsson, M Kjellberg, et al.
Scandinavian Journal of Rheumatology|February 9, 2016
Rheumatoid arthritis is still expensive in the new decade: a comparison between two early RA cohorts, diagnosed 1996-98 and 2006-09E Hallert, M Husberg, A Kalkan, et al.
Rheumatology (Oxford, England)|July 29, 2004
Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project)E Hallert, M Husberg, D Jonsson, et al.
Scandinavian Journal of Rheumatology|December 21, 2013
Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA projectE Hallert, M Husberg, A Kalkan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Differences Between Hypothetical and Experience-Based Value Sets for Eq-5d: Implications for Decision MakersM Aronsson, M Husberg, A Kalkan, et al.
Pageof 2